Sept 21 (Reuters) – Johnson & Johnson said on Monday its experimental use of Caplyta for bipolar mania met the main goal of a late-stage study, bringing the drug a step closer to expanding beyond its
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
HONG KONG LEGISLATIVE COUNCIL: CONDEMNS FOREIGN GOVERNMENTS' CRITICISM OF COURT RULING ON JOSHUA WONG (The…
Nov 6 (Reuters) - Microsoft is winding down an arrangement to rent AI computing from…
Nov 7 (Stats Perform) - Results from the NCAAB games on Friday (home team in…
Peyton McCollum had a game-high 14 points and Iowa thoroughly dominated Eastern Illinois 91-47 on…
Kevin Jennings passed for 350 yards and four touchdowns as SMU stayed in the hunt…
Nov 7 (Stats Perform) - Standings from the NHL games on Saturday Atlantic Division W…